Biodesign Surgisis Anterior Posterior Pelvic Floor Grafts

FDA 510(k) K130006 · Cook Biotech Incorporated

Substantially Equivalent

510(k) numberK130006

Submission

Device name
Biodesign Surgisis Anterior Posterior Pelvic Floor Grafts
Applicant
Cook Biotech Incorporated
West Lafayette, IN, US
Received
January 2, 2013
Decision date
April 5, 2013
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
PAI – Mesh, Surgical, Non-Synthetic, Urogynecologic, For Pelvic Organ Prolapse, Transvaginally Placed
Device class
Class III (high risk)
Regulation
21 CFR 884.5980
Specialty
Obstetrics/Gynecology
Implant
Yes

Tissue reinforcement of the fibromuscular layer of the pelvic floor when surgical treatment is indicated; procedures include anterior and posterior vaginal wall prolapse repair and vaginal apical and uterine prolapse repair completed transvaginally.

Other 510(k)s with product code PAI

510(k)DeviceApplicantDecision
K050355Permacol Surgical Implant T-Piece, Permacol Surgical Implant Rectocele-Piece, Models…PAI · Special Tissue Science Laboratories, Plc03/09/2005SE

More from Tissue Science Laboratories, Plc

510(k)DeviceDecision
K232646Biodesign Otologic Butterfly Graft (ENT-OTO-BFLY-0.4-0.6); Biodesign Otologic Butterfly…KHJ · Traditional 05/24/2024SE
K201000Biodesign Staple Line ReinforcementFTM · Traditional 07/13/2020SE
K191696Biodesign Anal Fistula Plug, Biodesign Fistula Plug, Biodesign Plastic Surgery Matrix…OXN · Traditional 12/27/2019SE
K171817Biodesign Diaphragmatic Hernia GraftFTM · Traditional 03/13/2018SE
K162934Biodesign Parastomal Hernia Repair GraftFTM · Traditional 07/10/2017SE
K170016Biodesign Fistula PlugFTM · Traditional 06/21/2017SE
K170945Biodesign Staple Line ReinforcementOXE · Special 04/28/2017SE
K161762DynaMatrix/Dynamatrix PlusNPL · Special 01/13/2017SE
K162741AxoGuard Nerve ConnectorJXI · Special 10/31/2016SE
K160136Flowable Wound MatrixKGN · Traditional 09/28/2016SE

Questions and answers

When was Biodesign Surgisis Anterior Posterior Pelvic Floor Grafts cleared by the FDA?

Biodesign Surgisis Anterior Posterior Pelvic Floor Grafts (K130006) received a 510(k) decision of Substantially Equivalent on April 5, 2013, 93 days after the submission was received.

What is the product code of K130006?

The FDA product code is PAI – Mesh, Surgical, Non-Synthetic, Urogynecologic, For Pelvic Organ Prolapse, Transvaginally Placed, a Class III (high risk) device regulated under 21 CFR 884.5980.